BISMUTH SUBSALICYLATE

BISMUTH SUBSALICYLATE was reported 5570 times

BISMUTH SUBSALICYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP DISORDER THERAPY 47 0.2374
1 APPENDICOLITH 89 0.2300
2 ANALGESIC THERAPY 51 0.1589
3 ANTACID THERAPY 19 0.1462
4 DRUG THERAPY 47 0.1386
5 CAPILLARY PERMEABILITY INCREASED 6 0.0923
6 BACTEROIDES INFECTION 21 0.0805
7 ANTICOAGULANT THERAPY 18 0.0634
8 MUSCLE TENSION DYSPHONIA 5 0.0625
9 MALIGNANT MELANOMA STAGE 0 11 0.0526
10 CONGENITAL HIATUS HERNIA 11 0.0482
11 CALCIUM DEFICIENCY 62 0.0478
12 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 50 0.0471
13 REBOUND ACID HYPERSECRETION 124 0.0410
14 NEPHROGENIC ANAEMIA 180 0.0388
15 ANDROGEN DEFICIENCY 12 0.0342
16 HYPERPARATHYROIDISM SECONDARY 83 0.0331
17 BLOOD PHOSPHORUS INCREASED 84 0.0307
18 HYPERPHOSPHATAEMIA 63 0.0293
19 END STAGE RENAL DISEASE 472 0.0259
20 COLD URTICARIA 5 0.0227
21 DEVICE WIRELESS COMMUNICATION ISSUE 5 0.0193
22 CHRONIC KIDNEY DISEASE 1419 0.0187
23 TOTAL LUNG CAPACITY DECREASED 28 0.0175
24 EYE SYMPTOM 6 0.0168
25 POLYSEROSITIS 7 0.0164
26 SMOKE SENSITIVITY 5 0.0162
27 OSTEOGENESIS IMPERFECTA 8 0.0137
28 IRON DEFICIENCY 60 0.0133
29 BLOOD URIC ACID INCREASED 77 0.0133
30 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 12 0.0129
31 TONGUE PRURITUS 11 0.0128
32 RENAL INJURY 327 0.0110
33 BLOOD CHROMOGRANIN A INCREASED 5 0.0109
34 APPENDICITIS 93 0.0099
35 HYPOPHOSPHATAEMIA 72 0.0097
36 GASTROINTESTINAL CANDIDIASIS 4 0.0095
37 BILIARY DYSKINESIA 16 0.0094
38 MYASTHENIA GRAVIS 76 0.0094
39 AORTIC STENOSIS 32 0.0092
40 AORTIC DISORDER 7 0.0089
41 VITAMIN D DEFICIENCY 86 0.0088
42 LUNG OPACITY 23 0.0087
43 VENTRICULAR FIBRILLATION 95 0.0085
44 CERVICAL RADICULOPATHY 6 0.0084
45 PARVOVIRUS B19 INFECTION 7 0.0078
46 MULTIPLE FRACTURES 128 0.0078
47 PATELLOFEMORAL PAIN SYNDROME 4 0.0078
48 INTERVERTEBRAL DISC DISPLACEMENT 4 0.0077
49 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 38 0.0075
50 VACCINATION COMPLICATION 6 0.0073
51 HELICOBACTER TEST POSITIVE 4 0.0071
52 BONE DISORDER 125 0.0069
53 FAECES DISCOLOURED 145 0.0067
54 NEPHROPATHY 62 0.0066
55 ADENOCARCINOMA GASTRIC 6 0.0065
56 RENAL HAEMANGIOMA 5 0.0063
57 FIBULA FRACTURE 18 0.0062
58 GASTROINTESTINAL HYPOMOTILITY 14 0.0062
59 TUBULOINTERSTITIAL NEPHRITIS 116 0.0062
60 CARDIOGENIC SHOCK 87 0.0061
61 ULNA FRACTURE 6 0.0061
62 CHOLECYSTITIS CHRONIC 39 0.0058
63 OSTEOPOROSIS 233 0.0057
64 RENAL FAILURE 726 0.0055
65 PANCREATIC ENZYMES INCREASED 8 0.0055
66 ACUTE KIDNEY INJURY 823 0.0054
67 LUMBAR RADICULOPATHY 6 0.0052
68 INFUSION SITE DISCHARGE 9 0.0051
69 INTERVERTEBRAL DISC DEGENERATION 47 0.0051
70 BEZOAR 7 0.0051
71 HAND FRACTURE 33 0.0047
72 ANAEMIA OF CHRONIC DISEASE 4 0.0044
73 RADIUS FRACTURE 10 0.0042
74 OSTEOPENIA 62 0.0041
75 TROPONIN INCREASED 31 0.0041
76 BACTERIAL INFECTION 74 0.0040
77 GASTROOESOPHAGEAL REFLUX DISEASE 315 0.0039
78 SPINAL OSTEOARTHRITIS 34 0.0039
79 INTERMITTENT CLAUDICATION 6 0.0038
80 HYPERLIPIDAEMIA 45 0.0038
81 BONE NEOPLASM 4 0.0037
82 FOOT FRACTURE 70 0.0037
83 ASCITES 108 0.0037
84 NEURALGIA 89 0.0037
85 PLEURITIC PAIN 10 0.0036
86 MULTIPLE ORGAN DYSFUNCTION SYNDROME 102 0.0036
87 IMPAIRED GASTRIC EMPTYING 49 0.0036
88 SPONDYLOLISTHESIS 6 0.0035
89 SPRUE-LIKE ENTEROPATHY 17 0.0034
90 EYELID PAIN 7 0.0034
91 TONGUE DISCOLOURATION 15 0.0034
92 BLOOD CALCIUM INCREASED 30 0.0034
93 CAPILLARY LEAK SYNDROME 7 0.0034
94 COLITIS MICROSCOPIC 16 0.0034
95 WRIST FRACTURE 40 0.0033
96 NORMOCHROMIC NORMOCYTIC ANAEMIA 10 0.0033
97 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 57 0.0033
98 SECONDARY ADRENOCORTICAL INSUFFICIENCY 5 0.0033
99 ESSENTIAL HYPERTENSION 6 0.0033
100 ANKLE FRACTURE 50 0.0032
101 MEGACOLON 5 0.0032
102 RESPIRATORY SYMPTOM 9 0.0032
103 INHIBITORY DRUG INTERACTION 5 0.0032
104 FRACTURED COCCYX 4 0.0032
105 ATROPHY 6 0.0031
106 COSTOCHONDRITIS 5 0.0031
107 SCOLIOSIS 19 0.0031
108 NON-HODGKIN'S LYMPHOMA 4 0.0031
109 GASTROENTERITIS NOROVIRUS 4 0.0030
110 GOUT 54 0.0030
111 TIBIA FRACTURE 14 0.0030
112 DIABETES INSIPIDUS 7 0.0029
113 CERVICAL SPINAL STENOSIS 5 0.0029
114 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 11 0.0029
115 ULCER 45 0.0028
116 VOCAL CORD PARALYSIS 5 0.0028
117 BENIGN PROSTATIC HYPERPLASIA 14 0.0027
118 INFUSION SITE SWELLING 17 0.0027
119 RENAL TUBULAR NECROSIS 26 0.0026
120 POLYCYSTIC OVARIES 4 0.0026
121 EARLY SATIETY 5 0.0026
122 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 10 0.0024
123 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 127 0.0024
124 GALLBLADDER DISORDER 43 0.0024
125 BILIARY COLIC 7 0.0024
126 LUMBAR SPINAL STENOSIS 7 0.0024
127 DILATATION VENTRICULAR 5 0.0024
128 INFUSION SITE BRUISING 5 0.0023
129 BURNS SECOND DEGREE 4 0.0023
130 BIPOLAR I DISORDER 5 0.0023
131 GASTROINTESTINAL ULCER 5 0.0023
132 BLOOD POTASSIUM ABNORMAL 6 0.0022
133 ARTHRITIS 174 0.0022
134 BLOOD TEST ABNORMAL 30 0.0021
135 FORCED EXPIRATORY VOLUME DECREASED 6 0.0021
136 MENISCUS INJURY 13 0.0021
137 PRE-EXISTING CONDITION IMPROVED 13 0.0021
138 EXOSTOSIS 19 0.0021
139 EPIGASTRIC DISCOMFORT 8 0.0020
140 LOWER LIMB FRACTURE 39 0.0020
141 JOINT INJURY 43 0.0020
142 SPUTUM DISCOLOURED 19 0.0020
143 CARPAL TUNNEL SYNDROME 28 0.0020
144 CATHETER SITE HAEMORRHAGE 5 0.0020
145 DIVERTICULUM 14 0.0020
146 BACK DISORDER 32 0.0020
147 CANCER PAIN 5 0.0020
148 POST-TRAUMATIC STRESS DISORDER 13 0.0019
149 CHEST INJURY 4 0.0019
150 ABDOMINAL DISTENSION 201 0.0019
151 LIGAMENT SPRAIN 19 0.0019
152 BLOOD CHOLESTEROL INCREASED 89 0.0019
153 SPINAL COLUMN STENOSIS 9 0.0019
154 ABDOMINAL ADHESIONS 6 0.0019
155 HYPONATRAEMIA 107 0.0019
156 ABDOMINAL MASS 5 0.0019
157 MIGRAINE WITH AURA 5 0.0018
158 CLAVICLE FRACTURE 7 0.0018
159 IRRITABLE BOWEL SYNDROME 39 0.0018
160 DIABETIC NEPHROPATHY 4 0.0018
161 OSTEOARTHRITIS 77 0.0018
162 DIABETES MELLITUS 138 0.0018
163 MACULE 5 0.0018
164 FAECES PALE 4 0.0018
165 ANXIETY DISORDER 6 0.0018
166 PROCTITIS 5 0.0018
167 CHOLECYSTITIS ACUTE 10 0.0018
168 PERIORBITAL OEDEMA 9 0.0017
169 IRON DEFICIENCY ANAEMIA 16 0.0017
170 UPPER LIMB FRACTURE 34 0.0017
171 CLOSTRIDIUM DIFFICILE COLITIS 18 0.0017
172 GLAUCOMA 32 0.0017
173 GASTROINTESTINAL INFLAMMATION 13 0.0017
174 BIPOLAR DISORDER 18 0.0017
175 HELICOBACTER INFECTION 17 0.0017
176 DRY MOUTH 134 0.0016
177 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
178 DYSPEPSIA 161 0.0016
179 SEASONAL ALLERGY 23 0.0016
180 BLOOD PRESSURE SYSTOLIC ABNORMAL 4 0.0016
181 OBSTRUCTIVE AIRWAYS DISORDER 18 0.0016
182 ABNORMAL FAECES 13 0.0016
183 TASTE DISORDER 32 0.0016
184 EXPOSURE TO TOXIC AGENT 5 0.0016
185 RALES 9 0.0015
186 FAECES HARD 6 0.0015
187 BONE DENSITY DECREASED 48 0.0015
188 CHOLELITHIASIS 50 0.0015
189 OESOPHAGEAL CANDIDIASIS 6 0.0015
190 POTENTIATING DRUG INTERACTION 5 0.0015
191 SLEEP DISORDER 103 0.0015
192 REGURGITATION 5 0.0015
193 SPINAL FRACTURE 29 0.0014
194 EYE DISCHARGE 15 0.0014
195 LARGE INTESTINE POLYP 10 0.0014
196 ACIDOSIS 11 0.0014
197 INFUSION SITE ERYTHEMA 12 0.0014
198 BREATH SOUNDS ABNORMAL 7 0.0014
199 PAPULE 10 0.0014
200 JOINT DISLOCATION 15 0.0014
201 DIABETIC NEUROPATHY 7 0.0014
202 MUCOUS STOOLS 7 0.0014
203 INTERVERTEBRAL DISC DISORDER 6 0.0014
204 MULTIPLE ALLERGIES 11 0.0014
205 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
206 CATARACT 83 0.0014
207 HYPERTONIC BLADDER 4 0.0014
208 HAEMORRHOIDS 27 0.0014
209 CONSTIPATION 300 0.0014
210 ASPIRATION 15 0.0014
211 FOOD INTOLERANCE 5 0.0014
212 NECK INJURY 4 0.0014
213 RIB FRACTURE 28 0.0014
214 PERIPHERAL VASCULAR DISORDER 7 0.0014
215 ATELECTASIS 13 0.0013
216 HAEMOLYTIC ANAEMIA 12 0.0013
217 ROTATOR CUFF SYNDROME 17 0.0013
218 CORONARY ARTERY DISEASE 40 0.0013
219 MELAENA 29 0.0013
220 ANORECTAL DISCOMFORT 7 0.0013
221 MICTURITION URGENCY 15 0.0013
222 HIATUS HERNIA 17 0.0013
223 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
224 FOOD POISONING 7 0.0013
225 FLATULENCE 73 0.0013
226 INTERVERTEBRAL DISC PROTRUSION 28 0.0013
227 ORAL INFECTION 5 0.0013
228 BLOOD CREATININE DECREASED 4 0.0013
229 INTENTIONAL PRODUCT MISUSE 111 0.0013
230 PATENT DUCTUS ARTERIOSUS 5 0.0013
231 ORTHOPNOEA 4 0.0013
232 GASTRIC DISORDER 43 0.0013
233 AZOTAEMIA 5 0.0013
234 DEPRESSION 282 0.0012
235 FAECES SOFT 9 0.0012
236 FACET JOINT SYNDROME 4 0.0012
237 INFLAMMATORY BOWEL DISEASE 12 0.0012
238 RENAL CELL CARCINOMA 6 0.0012
239 CHOLECYSTECTOMY 14 0.0012
240 CYTOPENIA 15 0.0012
241 VENTRICULAR SEPTAL DEFECT 7 0.0012
242 FREQUENT BOWEL MOVEMENTS 33 0.0012
243 THROMBOSIS 98 0.0012
244 ABDOMINAL DISCOMFORT 204 0.0012
245 INFUSION SITE HAEMORRHAGE 4 0.0012
246 HYPERVOLAEMIA 6 0.0012
247 HIP FRACTURE 39 0.0012
248 ABDOMINAL PAIN 282 0.0012
249 FEELING DRUNK 9 0.0012
250 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
251 PEPTIC ULCER 4 0.0012
252 ABDOMINAL PAIN UPPER 248 0.0012
253 BACK INJURY 13 0.0012
254 DIARRHOEA 771 0.0012
255 HYPERCHLORHYDRIA 7 0.0012
256 ERUCTATION 23 0.0012
257 BRONCHIECTASIS 8 0.0012
258 CARDIOVASCULAR DISORDER 30 0.0012
259 GASTROINTESTINAL PAIN 13 0.0012
260 BLOOD IRON DECREASED 14 0.0012
261 POOR PERIPHERAL CIRCULATION 5 0.0012
262 ALCOHOLISM 5 0.0012
263 INFUSION SITE PAIN 15 0.0012
264 TEARFULNESS 5 0.0012
265 SPINAL DISORDER 11 0.0012
266 MUSCLE STRAIN 10 0.0012
267 BONE CANCER 5 0.0011
268 HAEMORRHAGIC ANAEMIA 5 0.0011
269 HANGOVER 4 0.0011
270 SWELLING 106 0.0011
271 BONE LOSS 17 0.0011
272 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
273 BONE LESION 4 0.0011
274 GASTROENTERITIS VIRAL 20 0.0011
275 VASCULAR DEVICE INFECTION 5 0.0011
276 OESOPHAGITIS 12 0.0011
277 HYPOTHYROIDISM 35 0.0011
278 HYPERAESTHESIA 9 0.0011
279 MAJOR DEPRESSION 8 0.0011
280 LUMBAR VERTEBRAL FRACTURE 5 0.0011
281 PROCTALGIA 7 0.0011
282 INCREASED TENDENCY TO BRUISE 10 0.0011
283 HYPOMAGNESAEMIA 15 0.0011
284 SOMNAMBULISM 7 0.0011
285 CHRONIC SINUSITIS 4 0.0011
286 PULMONARY EMBOLISM 101 0.0011
287 PROTEIN TOTAL DECREASED 4 0.0011
288 FACE INJURY 4 0.0011
289 BOWEL MOVEMENT IRREGULARITY 8 0.0010
290 RENAL FAILURE CHRONIC 8 0.0010
291 OESOPHAGEAL ULCER 4 0.0010
292 SINUS CONGESTION 14 0.0010
293 HYPERCHOLESTEROLAEMIA 10 0.0010
294 HYPOALBUMINAEMIA 8 0.0010
295 EAR PAIN 20 0.0010
296 FIBROMYALGIA 25 0.0010
297 SEPSIS 114 0.0010
298 LUNG INFILTRATION 9 0.0010
299 PROSTATOMEGALY 4 0.0010
300 ONYCHOCLASIS 7 0.0010
301 FURUNCLE 8 0.0010
302 ABDOMINAL TENDERNESS 5 0.0010
303 GINGIVAL PAIN 8 0.0010
304 HEPATIC ENZYME ABNORMAL 5 0.0010
305 FOREIGN BODY 4 0.0010
306 GENERAL PHYSICAL HEALTH DETERIORATION 115 0.0010
307 DRUG INTOLERANCE 96 0.0010
308 GASTROINTESTINAL DISORDER 89 0.0010
309 FUNGAL SKIN INFECTION 4 0.0010
310 NERVE INJURY 11 0.0010
311 HOMICIDAL IDEATION 4 0.0010
312 ORAL PAIN 22 0.0010
313 SPINAL COMPRESSION FRACTURE 8 0.0010
314 VOMITING 454 0.0010
315 HAIR COLOUR CHANGES 12 0.0010
316 DRUG ERUPTION 17 0.0010
317 NASAL DRYNESS 6 0.0010
318 ARTERIOSCLEROSIS 9 0.0010
319 BLOOD LACTIC ACID INCREASED 5 0.0009
320 FULL BLOOD COUNT ABNORMAL 10 0.0009
321 HYPERPYREXIA 4 0.0009
322 FOREIGN BODY SENSATION IN EYES 6 0.0009
323 AORTIC VALVE INCOMPETENCE 4 0.0009
324 FEEDING DISORDER 19 0.0009
325 THROAT IRRITATION 42 0.0009
326 LIVER FUNCTION TEST INCREASED 20 0.0009
327 BLOOD MAGNESIUM DECREASED 8 0.0009
328 DECREASED ACTIVITY 10 0.0009
329 STRESS FRACTURE 5 0.0009
330 CHOLECYSTITIS 11 0.0009
331 PLEURAL EFFUSION 56 0.0009
332 POLYP 6 0.0009
333 DIVERTICULUM INTESTINAL 4 0.0009
334 GROIN PAIN 8 0.0009
335 PRODUCT FORMULATION ISSUE 6 0.0009
336 GRIP STRENGTH DECREASED 8 0.0009
337 ANGINA PECTORIS 26 0.0009
338 DEAFNESS UNILATERAL 5 0.0009
339 CHOKING SENSATION 5 0.0009
340 PROSTATIC DISORDER 5 0.0009
341 NOCTURIA 11 0.0009
342 ABDOMINAL ABSCESS 4 0.0009
343 GASTRIC ULCER HAEMORRHAGE 5 0.0009
344 PRODUCTIVE COUGH 43 0.0009
345 RETCHING 19 0.0009
346 COLITIS ISCHAEMIC 6 0.0009
347 OROPHARYNGEAL DISCOMFORT 8 0.0009
348 PAIN IN JAW 25 0.0009
349 RENAL CYST 7 0.0009
350 TRICUSPID VALVE INCOMPETENCE 7 0.0009
351 RENAL IMPAIRMENT 74 0.0009
352 GASTRITIS 23 0.0009
353 EAR DISORDER 4 0.0009
354 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
355 HUNGER 12 0.0009
356 SKIN WARM 5 0.0009
357 GASTRITIS EROSIVE 4 0.0009
358 LOWER RESPIRATORY TRACT INFECTION 39 0.0009
359 NAUSEA 675 0.0009
360 SKIN REACTION 12 0.0009
361 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
362 EATING DISORDER 18 0.0008
363 UPPER RESPIRATORY TRACT INFECTION 39 0.0008
364 FULL BLOOD COUNT DECREASED 17 0.0008
365 MOOD ALTERED 23 0.0008
366 SINUS HEADACHE 5 0.0008
367 RENAL DISORDER 39 0.0008
368 PROTHROMBIN TIME PROLONGED 5 0.0008
369 HAEMODIALYSIS 7 0.0008
370 FAECAL INCONTINENCE 4 0.0008
371 HUMERUS FRACTURE 4 0.0008
372 CANDIDA INFECTION 14 0.0008
373 NEPHROLITHIASIS 38 0.0008
374 ARTHROPATHY 46 0.0008
375 DENTAL CARIES 9 0.0008
376 PANCREATIC DISORDER 4 0.0008
377 LIMB INJURY 22 0.0008
378 SINUS DISORDER 16 0.0008
379 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
380 RED BLOOD CELL COUNT DECREASED 23 0.0008
381 BONE PAIN 47 0.0008
382 HYDRONEPHROSIS 6 0.0008
383 BLOOD CALCIUM DECREASED 9 0.0008
384 FLUID INTAKE REDUCED 4 0.0008
385 ANXIETY 227 0.0008
386 BLOOD URINE PRESENT 15 0.0008
387 POOR QUALITY SLEEP 17 0.0008
388 MUSCLE ATROPHY 10 0.0008
389 DERMATITIS CONTACT 9 0.0008
390 RESPIRATORY RATE INCREASED 7 0.0008
391 INSURANCE ISSUE 12 0.0008
392 GASTROINTESTINAL INFECTION 7 0.0008
393 PHARYNGEAL OEDEMA 12 0.0008
394 PERICARDIAL EFFUSION 18 0.0008
395 ANAL INCONTINENCE 7 0.0008
396 FOOD ALLERGY 6 0.0008
397 DECREASED APPETITE 180 0.0008
398 VENTRICULAR EXTRASYSTOLES 8 0.0008
399 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
400 DIVERTICULITIS 21 0.0008
401 DEHYDRATION 101 0.0008
402 MUSCULOSKELETAL DISCOMFORT 13 0.0008
403 APPETITE DISORDER 5 0.0008
404 SCIATICA 12 0.0008
405 BLOOD DISORDER 6 0.0007
406 FLANK PAIN 7 0.0007
407 COMPRESSION FRACTURE 4 0.0007
408 SENSORY LOSS 6 0.0007
409 HYPOPHAGIA 19 0.0007
410 GINGIVITIS 4 0.0007
411 ULCER HAEMORRHAGE 5 0.0007
412 ERYTHEMA OF EYELID 4 0.0007
413 DECUBITUS ULCER 6 0.0007
414 DYSURIA 27 0.0007
415 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
416 CARDIOMEGALY 9 0.0007
417 NEPHROTIC SYNDROME 5 0.0007
418 EYE PAIN 41 0.0007
419 ECONOMIC PROBLEM 11 0.0007
420 ILEUS 9 0.0007
421 BLOOD UREA INCREASED 12 0.0007
422 ATRIAL SEPTAL DEFECT 6 0.0007
423 SOMNOLENCE 144 0.0007
424 MALNUTRITION 8 0.0007
425 THYROID DISORDER 11 0.0007
426 PANIC ATTACK 26 0.0007
427 WEIGHT DECREASED 199 0.0007
428 MUSCULOSKELETAL CHEST PAIN 11 0.0007
429 TENDONITIS 11 0.0007
430 HOSPICE CARE 7 0.0007
431 BLOOD PRESSURE FLUCTUATION 17 0.0007
432 BLADDER DISORDER 7 0.0007
433 BLOOD CREATININE INCREASED 46 0.0007
434 BRAIN FOG 11 0.0007
435 IMPAIRED WORK ABILITY 15 0.0007
436 PRODUCT CONTAINER ISSUE 6 0.0007
437 HEPATIC STEATOSIS 13 0.0007
438 INJURY 49 0.0007
439 PARANOIA 12 0.0007
440 EXERCISE TOLERANCE DECREASED 4 0.0007
441 PANIC REACTION 5 0.0007
442 STOMATITIS 42 0.0007
443 PYELONEPHRITIS 6 0.0007
444 CYSTITIS 22 0.0007
445 DRY THROAT 7 0.0007
446 CRYING 25 0.0007
447 ANAEMIA 131 0.0007
448 NAIL DISORDER 6 0.0007
449 GASTRIC ULCER 13 0.0007
450 HAEMOPTYSIS 19 0.0007
451 ENERGY INCREASED 4 0.0007
452 EAR INFECTION 18 0.0007
453 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
454 URINARY INCONTINENCE 20 0.0007
455 ARTHROPOD BITE 5 0.0007
456 FACIAL PAIN 6 0.0007
457 WEIGHT FLUCTUATION 7 0.0007
458 GANGRENE 4 0.0007
459 PAROSMIA 5 0.0007
460 NECK PAIN 37 0.0007
461 TACHYPNOEA 9 0.0007
462 TENDON PAIN 5 0.0007
463 CORONARY ARTERY OCCLUSION 9 0.0007
464 PERIPHERAL COLDNESS 9 0.0007
465 CONGENITAL ANOMALY 5 0.0006
466 EYE IRRITATION 37 0.0006
467 OEDEMA PERIPHERAL 78 0.0006
468 BLOOD SODIUM DECREASED 12 0.0006
469 ABDOMINAL PAIN LOWER 16 0.0006
470 BLOOD ALBUMIN DECREASED 5 0.0006
471 HYPERSOMNIA 18 0.0006
472 OCULAR DISCOMFORT 7 0.0006
473 UTERINE CANCER 5 0.0006
474 STENT PLACEMENT 5 0.0006
475 HEART RATE IRREGULAR 14 0.0006
476 BACK PAIN 143 0.0006
477 CHEST PAIN 114 0.0006
478 CHOKING 12 0.0006
479 COELIAC DISEASE 6 0.0006
480 HEPATOMEGALY 6 0.0006
481 LIVER DISORDER 27 0.0006
482 ESCHERICHIA INFECTION 5 0.0006
483 DYSGRAPHIA 4 0.0006
484 HYPOTONIA 6 0.0006
485 INCORRECT PRODUCT ADMINISTRATION DURATION 13 0.0006
486 MENINGITIS 4 0.0006
487 ROAD TRAFFIC ACCIDENT 25 0.0006
488 SPLENOMEGALY 7 0.0006
489 HOT FLUSH 45 0.0006
490 BREAST MASS 4 0.0006
491 TRANSIENT ISCHAEMIC ATTACK 20 0.0006
492 FLUSHING 60 0.0006
493 ACUTE HEPATIC FAILURE 8 0.0006
494 INITIAL INSOMNIA 6 0.0006
495 TRANSAMINASES INCREASED 13 0.0006
496 EAR DISCOMFORT 6 0.0006
497 JOINT EFFUSION 4 0.0006
498 POOR VENOUS ACCESS 6 0.0006
499 SNEEZING 13 0.0006
500 LYMPHOEDEMA 4 0.0006
501 THERAPY NON-RESPONDER 26 0.0006
502 CARDIAC MURMUR 5 0.0006
503 SLEEP APNOEA SYNDROME 11 0.0006
504 MIGRAINE 55 0.0006
505 STAPHYLOCOCCAL INFECTION 19 0.0006
506 OROPHARYNGEAL PAIN 53 0.0006
507 CONDITION AGGRAVATED 174 0.0006
508 URINE OUTPUT DECREASED 5 0.0006
509 DEFAECATION URGENCY 4 0.0006
510 NEUROTOXICITY 10 0.0006
511 SMALL INTESTINAL OBSTRUCTION 7 0.0006
512 DUODENAL ULCER 4 0.0006
513 COUGH 159 0.0006
514 RESPIRATORY TRACT CONGESTION 9 0.0006
515 RENAL PAIN 6 0.0006
516 TINNITUS 26 0.0006
517 BLOOD POTASSIUM DECREASED 17 0.0006
518 FALL 188 0.0006
519 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
520 HAEMATOCHEZIA 31 0.0006
521 WRONG DRUG ADMINISTERED 5 0.0006
522 THERAPEUTIC RESPONSE UNEXPECTED 25 0.0006
523 NEUROPATHY PERIPHERAL 53 0.0006
524 COLITIS 21 0.0006
525 BLOOD PRESSURE ABNORMAL 11 0.0006
526 HYPERTHYROIDISM 8 0.0006
527 TOOTHACHE 10 0.0006
528 MUSCLE SPASMS 101 0.0005
529 RESTLESS LEGS SYNDROME 10 0.0005
530 SKIN LESION 15 0.0005
531 NASAL CONGESTION 32 0.0005
532 TOOTH FRACTURE 6 0.0005
533 ILLNESS 56 0.0005
534 NERVE COMPRESSION 5 0.0005
535 MENTAL STATUS CHANGES 15 0.0005
536 URINARY TRACT INFECTION 92 0.0005
537 HYPERTENSION 114 0.0005
538 LOCALISED INFECTION 13 0.0005
539 PULMONARY MASS 8 0.0005
540 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
541 TYPE 2 DIABETES MELLITUS 18 0.0005
542 INTESTINAL PERFORATION 6 0.0005
543 MUSCULOSKELETAL PAIN 28 0.0005
544 LACERATION 5 0.0005
545 ORAL CANDIDIASIS 7 0.0005
546 TOOTH INFECTION 7 0.0005
547 DYSPNOEA EXERTIONAL 20 0.0005
548 PULMONARY CONGESTION 7 0.0005
549 MITRAL VALVE INCOMPETENCE 6 0.0005
550 MENTAL DISORDER 23 0.0005
551 PERIPHERAL SWELLING 81 0.0005
552 HEART RATE INCREASED 52 0.0005
553 GASTRIC HAEMORRHAGE 6 0.0005
554 RHEUMATOID ARTHRITIS 59 0.0005
555 HERNIA 10 0.0005
556 RASH PRURITIC 28 0.0005
557 ELECTROLYTE IMBALANCE 6 0.0005
558 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 12 0.0005
559 PELVIC FRACTURE 4 0.0005
560 MUSCULOSKELETAL STIFFNESS 45 0.0005
561 SPINAL PAIN 6 0.0005
562 ASTHENIA 192 0.0005
563 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
564 AFFECTIVE DISORDER 4 0.0005
565 VITREOUS FLOATERS 5 0.0005
566 HEAD INJURY 16 0.0005
567 NASAL DISCOMFORT 4 0.0005
568 OBESITY 8 0.0005
569 APHONIA 7 0.0005
570 DRY EYE 25 0.0005
571 BURNING SENSATION 35 0.0005
572 CONTUSION 48 0.0005
573 FATIGUE 388 0.0005
574 DYSPNOEA 282 0.0005
575 NIGHT SWEATS 16 0.0005
576 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
577 FRUSTRATION TOLERANCE DECREASED 4 0.0005
578 ANHEDONIA 13 0.0005
579 TOOTH DISORDER 11 0.0005
580 MUSCLE TIGHTNESS 8 0.0005
581 MOTOR DYSFUNCTION 5 0.0005
582 LUNG DISORDER 24 0.0005
583 HICCUPS 4 0.0005
584 CHROMATURIA 11 0.0005
585 BRONCHITIS 36 0.0005
586 HYPERCALCAEMIA 6 0.0005
587 GENERALISED OEDEMA 6 0.0005
588 EYE SWELLING 18 0.0005
589 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
590 ACUTE CORONARY SYNDROME 4 0.0005
591 TENDERNESS 5 0.0005
592 GASTROENTERITIS 7 0.0005
593 BLOOD GLUCOSE DECREASED 23 0.0005
594 SINUSITIS 49 0.0005
595 DERMATITIS ALLERGIC 6 0.0005
596 HAEMATEMESIS 12 0.0005
597 INSOMNIA 126 0.0005
598 FLUID RETENTION 24 0.0005
599 RENAL FAILURE ACUTE 20 0.0005
600 BREAST PAIN 5 0.0005
601 RECTAL HAEMORRHAGE 20 0.0005
602 HYPOAESTHESIA ORAL 7 0.0005
603 DYSPHAGIA 44 0.0005
604 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
605 DIZZINESS 230 0.0005
606 NERVOUSNESS 24 0.0005
607 CHEST DISCOMFORT 47 0.0005
608 KIDNEY INFECTION 9 0.0005
609 INTENTIONAL DOSE OMISSION 13 0.0005
610 POLLAKIURIA 19 0.0005
611 PAIN IN EXTREMITY 134 0.0005
612 CONVULSION 26 0.0005
613 EPISTAXIS 34 0.0005
614 DEPRESSED MOOD 24 0.0005
615 BLOOD PRESSURE INCREASED 69 0.0005
616 ASTHMA 51 0.0005
617 BALANCE DISORDER 39 0.0005
618 INTESTINAL OBSTRUCTION 17 0.0005
619 VIRAL INFECTION 15 0.0005
620 FEELING ABNORMAL 108 0.0005
621 URINARY RETENTION 15 0.0004
622 GAIT DISTURBANCE 86 0.0004
623 GAIT INABILITY 15 0.0004
624 CARDIAC FAILURE CONGESTIVE 36 0.0004
625 GLOSSODYNIA 10 0.0004
626 CYANOSIS 7 0.0004
627 DYSKINESIA 18 0.0004
628 OSTEOMYELITIS 8 0.0004
629 PNEUMOTHORAX 7 0.0004
630 BODY TEMPERATURE INCREASED 9 0.0004
631 MYOCARDIAL ISCHAEMIA 5 0.0004
632 TACHYCARDIA 39 0.0004
633 PARAESTHESIA 69 0.0004
634 WHEEZING 26 0.0004
635 SCAB 5 0.0004
636 SKIN DISCOLOURATION 20 0.0004
637 MUSCULAR WEAKNESS 49 0.0004
638 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
639 CARDIO-RESPIRATORY ARREST 18 0.0004
640 LACRIMATION INCREASED 13 0.0004
641 MASS 6 0.0004
642 DISORIENTATION 17 0.0004
643 PRODUCT DOSE OMISSION 28 0.0004
644 DYSPHONIA 25 0.0004
645 BLISTER 24 0.0004
646 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 77 0.0004
647 PHOTOPHOBIA 8 0.0004
648 PAIN 261 0.0004
649 COVID-19 PNEUMONIA 5 0.0004
650 FRACTURE 8 0.0004
651 TREMOR 70 0.0004
652 PRODUCT PACKAGING ISSUE 4 0.0004
653 HYPOAESTHESIA 63 0.0004
654 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
655 LIMB DISCOMFORT 13 0.0004
656 FUNGAL INFECTION 14 0.0004
657 FEELING JITTERY 8 0.0004
658 FEMUR FRACTURE 13 0.0004
659 ACCIDENT 5 0.0004
660 RHINORRHOEA 27 0.0004
661 DYSGEUSIA 31 0.0004
662 HEPATITIS C 5 0.0004
663 EMOTIONAL DISTRESS 50 0.0004
664 DIZZINESS POSTURAL 4 0.0004
665 DYSTONIA 8 0.0004
666 UNEVALUABLE EVENT 31 0.0004
667 SKIN FISSURES 8 0.0004
668 ARTHRALGIA 170 0.0004
669 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
670 HAEMATOCRIT DECREASED 8 0.0004
671 PHARYNGITIS 5 0.0004
672 INABILITY TO AFFORD MEDICATION 4 0.0004
673 COLON CANCER 6 0.0004
674 NASOPHARYNGITIS 74 0.0004
675 LOCAL SWELLING 7 0.0004
676 CHILLS 47 0.0004
677 SECRETION DISCHARGE 5 0.0004
678 HEART RATE DECREASED 14 0.0004
679 PNEUMONIA 128 0.0004
680 GASTRIC CANCER 10 0.0004
681 SUICIDAL IDEATION 36 0.0004
682 THIRST 7 0.0004
683 PRODUCT USE IN UNAPPROVED INDICATION 97 0.0004
684 NEUTROPHIL COUNT INCREASED 4 0.0004
685 DRUG RESISTANCE 10 0.0004
686 EMOTIONAL DISORDER 12 0.0004
687 TREATMENT NONCOMPLIANCE 21 0.0004
688 PETECHIAE 4 0.0004
689 HEADACHE 240 0.0004
690 SPEECH DISORDER 20 0.0004
691 JOINT STIFFNESS 10 0.0004
692 VISION BLURRED 52 0.0004
693 PANCREATITIS 20 0.0004
694 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
695 VERTIGO 23 0.0004
696 INFLUENZA 42 0.0004
697 PLATELET COUNT DECREASED 40 0.0004
698 METABOLIC ACIDOSIS 12 0.0004
699 FEELING HOT 23 0.0004
700 CARDIAC DISORDER 35 0.0004
701 BODY HEIGHT DECREASED 4 0.0004
702 OXYGEN SATURATION DECREASED 21 0.0004
703 MALIGNANT MELANOMA 5 0.0004
704 VISUAL IMPAIRMENT 46 0.0004
705 HYPOGLYCAEMIA 18 0.0004
706 RESPIRATORY FAILURE 27 0.0004
707 ATRIAL FIBRILLATION 36 0.0004
708 PRODUCT TASTE ABNORMAL 5 0.0004
709 HYPOXIA 13 0.0004
710 GINGIVAL BLEEDING 5 0.0004
711 IMPAIRED HEALING 12 0.0004
712 PULMONARY FIBROSIS 7 0.0004
713 MALAISE 160 0.0004
714 ACUTE RESPIRATORY FAILURE 7 0.0004
715 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
716 EXPIRED PRODUCT ADMINISTERED 12 0.0004
717 PRODUCT DOSE OMISSION ISSUE 106 0.0004
718 COAGULOPATHY 6 0.0004
719 ORAL DISCOMFORT 5 0.0004
720 FEELING COLD 10 0.0004
721 ARRHYTHMIA 17 0.0004
722 MYALGIA 61 0.0004
723 PYREXIA 124 0.0004
724 PULMONARY OEDEMA 16 0.0004
725 NEPHROPATHY TOXIC 4 0.0004
726 EYE INFECTION 4 0.0004
727 DEEP VEIN THROMBOSIS 23 0.0004
728 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
729 COVID-19 62 0.0004
730 SWELLING FACE 23 0.0004
731 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
732 NERVOUS SYSTEM DISORDER 11 0.0004
733 DIALYSIS 5 0.0004
734 IMPAIRED DRIVING ABILITY 4 0.0004
735 NEOPLASM 4 0.0003
736 NIGHTMARE 12 0.0003
737 PARAESTHESIA ORAL 5 0.0003
738 PRURITUS 133 0.0003
739 MADAROSIS 4 0.0003
740 HYPERKALAEMIA 12 0.0003
741 MEMORY IMPAIRMENT 47 0.0003
742 HYPERHIDROSIS 44 0.0003
743 HAEMOGLOBIN DECREASED 35 0.0003
744 LACTIC ACIDOSIS 11 0.0003
745 HYPOTENSION 68 0.0003
746 ATAXIA 4 0.0003
747 PULMONARY HYPERTENSION 7 0.0003
748 COLITIS ULCERATIVE 15 0.0003
749 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
750 INTENTIONAL DRUG MISUSE 7 0.0003
751 RASH ERYTHEMATOUS 16 0.0003
752 DISTURBANCE IN ATTENTION 18 0.0003
753 PALPITATIONS 39 0.0003
754 INFECTION 48 0.0003
755 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
756 BURSITIS 4 0.0003
757 ADRENAL INSUFFICIENCY 4 0.0003
758 OFF LABEL USE 287 0.0003
759 BLOOD GLUCOSE ABNORMAL 6 0.0003
760 MEDICATION ERROR 18 0.0003
761 CYST 4 0.0003
762 WOUND 9 0.0003
763 SWOLLEN TONGUE 10 0.0003
764 MOBILITY DECREASED 23 0.0003
765 DYSARTHRIA 12 0.0003
766 BRAIN OEDEMA 4 0.0003
767 INCREASED APPETITE 6 0.0003
768 OEDEMA 17 0.0003
769 POST PROCEDURAL COMPLICATION 6 0.0003
770 SENSORY DISTURBANCE 5 0.0003
771 DISCOMFORT 19 0.0003
772 ANAPHYLACTIC SHOCK 8 0.0003
773 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
774 SKIN ULCER 8 0.0003
775 DYSSTASIA 9 0.0003
776 PRODUCT AVAILABILITY ISSUE 7 0.0003
777 RESPIRATORY TRACT INFECTION 8 0.0003
778 CEREBROVASCULAR ACCIDENT 52 0.0003
779 PLATELET COUNT INCREASED 4 0.0003
780 JOINT SWELLING 37 0.0003
781 MANIA 5 0.0003
782 INFLUENZA LIKE ILLNESS 25 0.0003
783 CONFUSIONAL STATE 49 0.0003
784 HYPOACUSIS 13 0.0003
785 BLOOD PRESSURE DECREASED 20 0.0003
786 PRESCRIBED UNDERDOSE 6 0.0003
787 LIP SWELLING 10 0.0003
788 SKIN DISORDER 10 0.0003
789 NEOPLASM MALIGNANT 20 0.0003
790 HEPATIC FAILURE 9 0.0003
791 URTICARIA 50 0.0003
792 CELLULITIS 15 0.0003
793 PRODUCT ADMINISTRATION ERROR 6 0.0003
794 EXTRA DOSE ADMINISTERED 12 0.0003
795 HERPES ZOSTER 17 0.0003
796 PALLOR 8 0.0003
797 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
798 ABNORMAL DREAMS 8 0.0003
799 TOOTH LOSS 6 0.0003
800 ORTHOSTATIC HYPOTENSION 5 0.0003
801 DRUG-INDUCED LIVER INJURY 9 0.0003
802 DEMENTIA 8 0.0003
803 LIVER INJURY 7 0.0003
804 ALOPECIA 56 0.0003
805 ENCEPHALOPATHY 7 0.0003
806 SKIN EXFOLIATION 24 0.0003
807 HALLUCINATION, VISUAL 6 0.0003
808 BLINDNESS UNILATERAL 4 0.0003
809 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
810 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
811 HEAD DISCOMFORT 5 0.0003
812 MOVEMENT DISORDER 9 0.0003
813 HALLUCINATION 21 0.0003
814 LETHARGY 16 0.0003
815 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
816 TREATMENT FAILURE 23 0.0003
817 PELVIC PAIN 5 0.0003
818 HYPERSENSITIVITY 51 0.0003
819 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
820 LOSS OF CONSCIOUSNESS 35 0.0003
821 TOXICITY TO VARIOUS AGENTS 46 0.0003
822 WEIGHT INCREASED 61 0.0003
823 UNRESPONSIVE TO STIMULI 7 0.0003
824 PSYCHOTIC DISORDER 8 0.0003
825 RASH GENERALISED 7 0.0003
826 RASH MACULO-PAPULAR 6 0.0003
827 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
828 EYE PRURITUS 9 0.0003
829 MIDDLE INSOMNIA 5 0.0003
830 DEAFNESS 7 0.0003
831 SEDATION 7 0.0003
832 PANCREATITIS ACUTE 6 0.0003
833 ANGER 9 0.0003
834 PRODUCT USE ISSUE 50 0.0003
835 THERAPY INTERRUPTED 19 0.0003
836 APHASIA 8 0.0003
837 BLOOD COUNT ABNORMAL 4 0.0003
838 RASH 115 0.0003
839 MYOCARDIAL INFARCTION 46 0.0003
840 INJECTION SITE BRUISING 21 0.0003
841 MUSCULOSKELETAL DISORDER 5 0.0003
842 HIP ARTHROPLASTY 4 0.0003
843 FEAR 7 0.0003
844 HYPOKALAEMIA 12 0.0003
845 DEVICE RELATED INFECTION 4 0.0003
846 RASH MACULAR 9 0.0003
847 BASAL CELL CARCINOMA 4 0.0003
848 PRODUCT USE COMPLAINT 4 0.0003
849 RESPIRATORY DISTRESS 7 0.0003
850 DISABILITY 5 0.0003
851 DRUG INTERACTION 40 0.0003
852 MOOD SWINGS 8 0.0003
853 MULTIPLE SCLEROSIS 12 0.0003
854 INCORRECT DRUG ADMINISTRATION DURATION 7 0.0002
855 DRUG EFFECT INCOMPLETE 9 0.0002
856 AMNESIA 16 0.0002
857 AGITATION 18 0.0002
858 OSTEONECROSIS 8 0.0002
859 OSTEONECROSIS OF JAW 6 0.0002
860 CARDIAC ARREST 20 0.0002
861 PHOTOSENSITIVITY REACTION 4 0.0002
862 PNEUMONIA ASPIRATION 6 0.0002
863 MOUTH ULCERATION 5 0.0002
864 FACE OEDEMA 4 0.0002
865 DRUG INEFFECTIVE 312 0.0002
866 COGNITIVE DISORDER 11 0.0002
867 SEIZURE 27 0.0002
868 PANCYTOPENIA 13 0.0002
869 SKIN CANCER 5 0.0002
870 HAEMATOMA 6 0.0002
871 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
872 RENAL CANCER 11 0.0002
873 SUICIDE ATTEMPT 14 0.0002
874 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
875 DRUG ADMINISTRATION ERROR 7 0.0002
876 COMPLETED SUICIDE 19 0.0002
877 METASTASES TO LIVER 4 0.0002
878 DEATH 196 0.0002
879 ABNORMAL BEHAVIOUR 9 0.0002
880 PAIN OF SKIN 6 0.0002
881 THROAT TIGHTNESS 6 0.0002
882 SURGERY 13 0.0002
883 LEUKOCYTOSIS 4 0.0002
884 PNEUMONITIS 6 0.0002
885 HYPERGLYCAEMIA 8 0.0002
886 INJECTION SITE REACTION 15 0.0002
887 RESPIRATORY ARREST 6 0.0002
888 PROCEDURAL PAIN 6 0.0002
889 INCORRECT DOSE ADMINISTERED 49 0.0002
890 THERAPY CESSATION 11 0.0002
891 TARDIVE DYSKINESIA 6 0.0002
892 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
893 DISEASE PROGRESSION 25 0.0002
894 INFUSION RELATED REACTION 14 0.0002
895 FEBRILE NEUTROPENIA 14 0.0002
896 OCULAR HYPERAEMIA 10 0.0002
897 SYNCOPE 21 0.0002
898 HOSPITALISATION 32 0.0002
899 INTERSTITIAL LUNG DISEASE 10 0.0002
900 DRUG DOSE OMISSION 34 0.0002
901 PRESYNCOPE 5 0.0002
902 HAEMATURIA 7 0.0002
903 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
904 INJECTION SITE URTICARIA 5 0.0002
905 ANGIOEDEMA 9 0.0002
906 LABORATORY TEST ABNORMAL 6 0.0002
907 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
908 RESPIRATORY DISORDER 6 0.0002
909 AGEUSIA 5 0.0002
910 PRODUCT PHYSICAL ISSUE 4 0.0002
911 LUNG NEOPLASM MALIGNANT 8 0.0002
912 INFLAMMATION 10 0.0002
913 ACCIDENTAL OVERDOSE 7 0.0002
914 HAEMORRHAGE 20 0.0002
915 RESTLESSNESS 7 0.0002
916 OVERDOSE 41 0.0002
917 ADVERSE DRUG REACTION 17 0.0002
918 THROMBOCYTOPENIA 21 0.0002
919 ERYTHEMA 38 0.0002
920 UNDERDOSE 13 0.0002
921 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
922 HEPATIC ENZYME INCREASED 12 0.0002
923 NEOPLASM PROGRESSION 6 0.0002
924 LIVER FUNCTION TEST ABNORMAL 5 0.0002
925 BLINDNESS 7 0.0002
926 INJECTION SITE SWELLING 13 0.0002
927 LYMPHADENOPATHY 6 0.0002
928 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
929 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
930 COMA 8 0.0002
931 MENTAL IMPAIRMENT 4 0.0002
932 BLOOD GLUCOSE INCREASED 31 0.0002
933 INJECTION SITE RASH 5 0.0002
934 PRODUCT QUALITY ISSUE 22 0.0002
935 ABASIA 4 0.0002
936 EXTRAPYRAMIDAL DISORDER 4 0.0002
937 DRY SKIN 21 0.0002
938 HEPATITIS 4 0.0002
939 PRODUCT SUBSTITUTION ISSUE 9 0.0002
940 NEUTROPENIA 21 0.0002
941 EYE DISORDER 5 0.0002
942 ADVERSE EVENT 14 0.0002
943 IRRITABILITY 9 0.0001
944 JAUNDICE 4 0.0001
945 ILL-DEFINED DISORDER 9 0.0001
946 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
947 INJECTION SITE ERYTHEMA 18 0.0001
948 RHABDOMYOLYSIS 6 0.0001
949 WITHDRAWAL SYNDROME 6 0.0001
950 AGGRESSION 7 0.0001
951 CEREBRAL HAEMORRHAGE 5 0.0001
952 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
953 PANCREATIC CARCINOMA 4 0.0001
954 DEVICE DISLOCATION 6 0.0001
955 SEPTIC SHOCK 6 0.0001
956 NEEDLE ISSUE 4 0.0001
957 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
958 OESOPHAGEAL CARCINOMA 4 0.0001
959 HEPATIC FUNCTION ABNORMAL 5 0.0001
960 THERAPEUTIC RESPONSE DECREASED 8 0.0001
961 INJECTION SITE PAIN 40 0.0001
962 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
963 PLASMA CELL MYELOMA 5 0.0001
964 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
965 INJECTION SITE HAEMORRHAGE 10 0.0001
966 PSORIATIC ARTHROPATHY 5 0.0001
967 VAGINAL HAEMORRHAGE 5 0.0001
968 ECZEMA 6 0.0001
969 PRODUCT STORAGE ERROR 10 0.0001
970 DISEASE RECURRENCE 5 0.0001
971 DRUG WITHDRAWAL SYNDROME 9 0.0001
972 PROSTATE CANCER 8 0.0001
973 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
974 NEUTROPHIL COUNT DECREASED 4 0.0001
975 BREAST CANCER 9 0.0001
976 EXPOSURE DURING PREGNANCY 6 0.0001
977 BRADYCARDIA 5 0.0001
978 ACNE 7 0.0001
979 DEVICE LEAKAGE 4 0.0001
980 ANAPHYLACTIC REACTION 5 0.0001
981 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
982 INJECTION SITE PRURITUS 6 0.0001
983 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
984 DEVICE ISSUE 7 0.0001
985 DRUG EFFECT DECREASED 4 0.0001
986 DRUG ABUSE 6 0.0001
987 SKIN BURNING SENSATION 5 0.0001
988 BLADDER CANCER 4 0.0001
989 INTENTIONAL OVERDOSE 4 0.0001
990 CARDIAC FAILURE 5 0.0001
991 PSORIASIS 8 0.0001
992 DEVICE MALFUNCTION 4 0.0001
993 NO ADVERSE EVENT 9 0.0000
994 DRUG DEPENDENCE 7 0.0000